Posted:
3/30/2025, 11:23:28 PM
Location(s):
Massachusetts, United States ⋅ Cambridge, Massachusetts, United States
Experience Level(s):
Senior
Field(s):
Medical, Clinical & Veterinary
Role Summary
The Internal Medicine Research Unit (IMRU), is focused on developing novel therapies to address key unmet needs in cardiovascular and renal disease. As a key member of the Internal Medicine Research Unit leadership team, this individual will be responsible for formulating and implementing a cardio-renal therapeutic strategy as well as leading a team of researchers to create a portfolio of discovery projects from ideation to clinical candidate selection. This leader will develop a data-driven research strategy for identification and validation of targets for drug discovery and disease/target related biomarkers. Substantial knowledge and experience in basic cardio-renal biology are essential, as is evidence of substantive accomplishments in the areas of renal and/or cardiovascular disease. In addition, the individual will build and facilitate collaborations with partners in the scientific community, as well as within the Pfizer network. He/she will have daily interactions with and supervision of a team of 20-25 creative and innovative scientists in a supportive environment to conduct rigorous scientific and drug discovery research. Strong self-motivation, excellent communication and interpersonal skills, and the ability to lead and work as part of a team are essential qualities of the role.
Role Responsibilities
Successful candidates will be expected to:
Basic Qualifications
Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.
Preferred Qualifications
Other Information
Relocation assistance may be available based on business needs and/or eligibility.
Sunshine Act
Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care provider’s name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.
EEO & Employment Eligibility
Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer. This position requires permanent work authorization in the United States.
Website: https://www.pfizer.com/
Headquarter Location: New York, New York, United States
Employee Count: 10001+
Year Founded: 1849
IPO Status: Public
Last Funding Type: Post-IPO Debt
Industries: Biotechnology ⋅ Health Care ⋅ Medical ⋅ Pharmaceutical ⋅ Precision Medicine